IG Living Advocate Podcast

Every quarter IG Living will hold a podcast on a topic that affects those with autoimmune and immunodeficiency disorders. Industry experts will share the latest immune globulin (IG) news and information and answer questions from our community.

Podcasts will cover topics like the increased demand for IG products, Medicare, IG side effects, and reimbursement. more info

Listen to the episode The Increased Demand for Immune Globulin Products and Its Effects on Patient Access.

To receive notifications about upcoming podcasts, subscribe to IG Living Magazine. subscribe now

Picture of Carl Schlacht


Let's Talk: Michelle Searle

As a young adult living with common variable immune deficiency (CVID), Michelle Searle has been fearlessly pursuing her dreams and refusing to let her primary immunodeficiency disease (PI) hold her back. After spending several years as a teen advocate for the Immune Deficiency Foundation (IDF), Michelle is now living abroad in Italy where she is fulfilling her goal of obtaining dual citizenship and embarking on a teaching career. With tenacity and grit, Michelle is an inspiration for anyone who strives to live life without limitations, ignoring the naysayers and maintaining a positive outlook no matter what… full article (pdf)

Product Guide: Personalizing the Infusion Experience

Product Guide

Safely Soaking Up the Sun

The sun is not only essential to survival, it can boost mood and well-being. Yet, it can also be deadly. Most skin cancers are caused by an excessive amount of exposure to ultraviolet (UV) rays, the radiation emitted from sunlight. Fortunately, there are many ways to enjoy fun-filled outdoor activities while protecting the skin and eyes from harmful rays… full article (pdf)

Chat conversation word balloons

Ask the Experts

Reader: Will immune globulin replacement therapy cause severe side effects in patients with polyclonal IgA hypergammaglobulinemia?

Abbie: I spoke with a couple of our experts regarding your question. They said they have treated patients with multiple myeloma and high IgA who do well with IG treatment, and there should be no major issues with IG therapy, especially if it is infused subcutaneously (SCIG)… full article (pdf)

Meet the Staff

Cheryl Brooks
Assistant Editor

Abbie Cornett
Patient Advocate

Advisory Board

Bob Geng, MD, MA
Assistant Professor, Division of Allergy & Immunology
University of California, San Diego

Terry O. Harville,

Medical Director Special Immunology Laboratory University of Arkansas for Medical Sciences

Todd Levine, MD
Director, Department of Neurophysiology Good Samaritan Hospital, Phoenix
Assistant Professor of Clinical Neurology University of Arizona

Fred Modell
Co-founder of the Jeffrey Modell Foundation

Marc Riedl, MD, MS
Associate Professor of Medicine Division of Rheumatology, Allergy & Immunology University of California, San Diego